America leads on Alzheimer’s innovation. China actually takes it seriously
New polling from the Market Institute and President Donald Trump’s pollster Fabrizio Ward finds that an overwhelming 87% of voters believe fighting Alzheimer’s should be a priority. Nearly 4 in 5 say they are more likely to support candidates who prioritize better access to Alzheimer’s detection, diagnosis, and treatment.
The good news is these results coincide with rapid American innovation in Alzheimer’s research and treatment. New research suggests as many as 45% of dementia cases may be linked to potentially modifiable risk factors, meaning earlier action can change outcomes. American companies have developed blood-based biomarker tests capable of detecting markers associated with Alzheimer’s disease through a simple blood draw and treatments designed to slow disease progression.
